Your Guide to Ozempic: Understanding What’s the Doses for Your Journey

Last reviewed: July 6, 2026

Last updated: July 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works through a structured dosing protocol that allows your body to adapt to the medication while minimizing side effects. Most patients begin at a low starting dose and progress upward based on individual tolerance and response. Clinical studies show this stepwise approach leads to sustained weight loss while improving medication tolerability.

How Semaglutide Dosing Schedules Work

Semaglutide initiates treatment with a 0.25 mg weekly injection during the first four weeks. This foundational dose allows your body's GLP-1 receptors to become activated without overwhelming your system. The low starting point reduces nausea and gastrointestinal adjustment compared to higher initial doses, making the transition smoother for most patients.

Week five through eight increases your dose to 0.5 mg weekly as your body demonstrates tolerance. This measured progression ensures you're receiving enough medication to trigger appetite suppression and metabolic changes without excessive side effects. Your healthcare provider monitors this phase to determine if you're ready to advance further.

Understanding Progressive Dose Escalation

Between weeks nine and twelve, your semaglutide dose moves to 1.0 mg weekly. At this level, most patients experience noticeable appetite reduction and begin tracking meaningful weight loss. Many individuals stabilize at this dose if they achieve their desired results, while others continue titrating based on clinical assessment.

The final maintenance phase reaches 2.4 mg weekly, which represents the maximum therapeutic dose used in most weight loss protocols. Not every patient requires this level—some achieve excellent results at 1.7 mg or 2.0 mg. Your response to earlier doses determines whether escalation beyond 1.0 mg aligns with your specific needs and tolerance profile.

Why Dose Titration Protects Your Health

Gradual dose increases reduce the risk of severe nausea, vomiting, and gastrointestinal distress that can occur with rapid escalation. Your pancreas, liver, and digestive system adapt progressively to semaglutide's mechanism of action, which stabilizes blood sugar and slows gastric emptying. This adaptation period is clinically essential for long-term treatment success and medication adherence.

Safety monitoring during titration includes tracking your body's tolerance signals and adjusting timelines when needed. Some patients remain at a specific dose longer than the standard four-week intervals if they experience side effects. PlexusDx's medical team personalizes your escalation schedule to match your individual physiology rather than forcing a one-size-fits-all timeline.

Personalized Dosing With Genetic Insight

The PlexusDx Precision Peptide Genetic Test analyzes FTO (rs9939609) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Understanding your genetic predispositions helps your provider establish realistic goals for your specific dose journey. Some patients achieve maximum benefit at 1.0 mg due to favorable genetic markers, while others benefit from advancing to 2.4 mg. This personalized approach means your treatment plan reflects your biology, not a generic protocol.

Pricing Remains Consistent Across Your Dosing Journey

PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan regardless of your dose level. Your dose may need to go up during your four-week titration phases, but your monthly price won't change. This flat-rate pricing removes financial barriers as you progress through your treatment protocol.

All semaglutide from PlexusDx comes from licensed 503A compounding pharmacies and is available across all 50 states without insurance requirements. Your treatment is HSA/FSA eligible, and optional genetic testing ($298) provides precise dosing guidance. When you need to escalate, you're investing in your health without facing unexpected cost increases.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What is the typical starting dose of semaglutide for weight loss?

The standard starting dose is 0.25 mg weekly for four weeks, allowing your body to acclimate to the medication. This low entry point minimizes side effects while beginning GLP-1 receptor activation. Your provider may adjust timing based on your individual tolerance.

How long does it take to reach the maximum dose?

Most patients reach the 2.4 mg maintenance dose after 16 weeks following the standard four-week escalation intervals at 0.25, 0.5, 1.0, 1.7, 2.0, and 2.4 mg. Some individuals stabilize at lower doses if they achieve significant weight loss and good tolerability. Your timeline depends on your response rather than a fixed schedule.

Does PlexusDx charge more as my semaglutide dose increases?

No—PlexusDx compounded semaglutide injections remain $189 per month flat across all dose levels. Your price stays constant whether you're at 0.25 mg or 2.4 mg, making long-term treatment predictable and affordable.

What side effects should I expect during dose escalation?

Nausea, reduced appetite, and mild gastrointestinal changes are common during early titration but typically diminish as your body adapts. Serious side effects are rare when following a gradual escalation schedule. Report persistent symptoms to your provider, who can slow your progression if needed.

How does the Precision Peptide Genetic Test improve my dosing plan?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Lifemd Ozempic
• Eden Ozempic
• Ro Ozempic
• Mochi Ozempic

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.